0001103021-22-000019.txt : 20220131 0001103021-22-000019.hdr.sgml : 20220131 20220131175957 ACCESSION NUMBER: 0001103021-22-000019 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220127 FILED AS OF DATE: 20220131 DATE AS OF CHANGE: 20220131 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Golubieski John CENTRAL INDEX KEY: 0001610695 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31361 FILM NUMBER: 22575859 MAIL ADDRESS: STREET 1: C/O LANTHEUS HOLDINGS, INC. STREET 2: 331 TREBLE COVE ROAD CITY: NORTH BILLERICA STATE: NY ZIP: 01862 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIODELIVERY SCIENCES INTERNATIONAL INC CENTRAL INDEX KEY: 0001103021 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 352089858 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4131 PARKLAKE AVENUE STREET 2: SUITE 225 CITY: RALEIGH STATE: NC ZIP: 27612 BUSINESS PHONE: 919 582 9050 MAIL ADDRESS: STREET 1: 4131 PARKLAKE AVENUE STREET 2: SUITE 225 CITY: RALEIGH STATE: NC ZIP: 27612 FORMER COMPANY: FORMER CONFORMED NAME: MAS ACQUISITION XXIII CORP DATE OF NAME CHANGE: 20000111 4 1 wf-form4_164366997243576.xml FORM 4 X0306 4 2022-01-27 0 0001103021 BIODELIVERY SCIENCES INTERNATIONAL INC BDSI 0001610695 Golubieski John 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612 0 1 0 0 See Remarks Stock Options (right to buy) 3.66 2022-01-27 4 A 0 373533 3.66 A 2032-01-26 Common Stock 373533.0 373533 D Restricted Stock Units 0.0 2022-01-27 4 A 0 66940 0 A 2025-01-27 Common Stock 66940.0 66940 D The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on January 27, 2022. The stock options were issued to the Reporting Person on January 27, 2022, pursuant to a grant under the Issuer's 2019 Stock Option Incentive Plan (the "Plan"). The award is subject to time-based vesting and will vest in equal portions on: (i) January 27, 2023; (ii) January 27, 2024; and (iii) January 27, 2025. The Restricted Stock Units ("RSUs") were issued to the Reporting Person on January 27, 2022, pursuant to a grant under the Plan. The award is subject to time-based vesting and will vest in equal portions on: (i) January 27, 2023; (ii) January 27, 2024; and (iii) January 27, 2025. Upon vesting, each RSU entitles the Reporting Person to one share of the Issuer's common stock. Chief Financial Officer and Treasurer John Golubieski 2022-01-31